Zhejiang Yatai Pharmaceutical News

Asia Pacific Pharmaceutical: Announcement on Atomic Company\'s completion of the registration of capital reduction and commercial changes

Nov 11 11:00 ET

Asia Pacific Pharmaceutical: Announcement on the progress of liquidation and cancellation of joint ventures

Oct 31 12:00 ET

Asia Pacific Pharmaceutical: Announcement on the conversion of convertible corporate bonds to shares in the third quarter of 2024

Oct 8 12:00 ET

Asia Pacific Pharmaceutical: Announcement on Sale of 100% Shares in Wholly-owned Subsidiaries and Debt Forgiveness

Sep 9 12:00 ET

Asia Pacific Pharmaceutical: Progress Notice on Litigation Matters

Sep 9 12:00 ET

Asia Pacific Pharmaceutical: Notice on receiving the acceptance notice for the consistency evaluation of atenolol tablets

Sep 6 12:00 ET

Zhejiang Yatai Pharmaceutical: Financial Report for the first half of 2024.

Aug 23 12:00 ET

Zhejiang Yatai Pharmaceutical: Summary table of non-operating funds utilization and other related funds flow for the first half of the year.

Aug 23 12:00 ET

Zhejiang Yatai Pharmaceutical: Announcement Regarding Not Lowering the Conversion Price of Yayao Convertible Bonds to Equity

Jul 25 12:00 ET

Zhejiang Yatai Pharmaceutical: Announcement on changing the continuously supervised sponsoring representative.

Jul 25 12:00 ET

Zhejiang Yatai Pharmaceutical: Announcement on the expected downward revision of the conversion price trigger conditions for Asia Pharmaceutical Convertible Bonds.

Jul 18 12:00 ET

Zhejiang Yatai Pharmaceutical: Announcement on the Progress of Bankruptcy Liquidation of Subsidiary

Jul 2 12:00 ET

Zhejiang Yatai Pharmaceutical: Legal opinion of Peking Guofeng on the interim shareholders' meeting of Zhejiang Yatai Pharmaceutical in 2024

Jul 1 12:00 ET

Zhejiang Yatai Pharmaceutical: Announcement of the resolution of the first extraordinary Shareholders' Meeting in 2024.

Jul 1 12:00 ET

Zhejiang Yatai Pharmaceutical: Announcement on the progress of the liquidation and cancellation of the joint venture company.

Jul 1 12:00 ET

Zhejiang Yatai Pharmaceutical: Announcement of convertible bond conversion into stocks for the second quarter of 2024.

Jul 1 12:00 ET

Zhejiang Yatai Pharmaceutical: Announcement Regarding Downward Revision of Convertible Corporate Bond Conversion Price

Jul 1 12:00 ET

Zhejiang Yatai Pharmaceutical: Tracking rating of the public issuance of convertible corporate bonds by Zhejiang Yatai Pharmaceutical Co., Ltd.

Jun 28 12:00 ET

Zhejiang Yatai Pharmaceutical: Notice of the First Extraordinary Shareholders' Meeting in 2024

Jun 13 12:00 ET

Zhejiang Yatai Pharmaceutical: Notice Regarding the Board of Directors Proposal to Downwardly Revise the Convertible Corporate Bond Conversion Price.

Jun 13 12:00 ET